Order Article Reprints

Sollena P, Vasiliki N, Kotteas E, Stratigos AJ, Fattore D, Orlandi A, Mannino M, Di Pumpo M, Fida M, Starace M, et al. Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study. Cancers. 2023; 15(14):3658. https://doi.org/10.3390/cancers15143658

Sollena, Pietro, Nikolaou Vasiliki, Elias Kotteas, Alexander J. Stratigos, Davide Fattore, Armando Orlandi, Maria Mannino, Marcello Di Pumpo, Monika Fida, Michela Starace, and et al. 2023. "Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study" Cancers 15, no. 14: 3658. https://doi.org/10.3390/cancers15143658

Sollena, P., Vasiliki, N., Kotteas, E., Stratigos, A. J., Fattore, D., Orlandi, A., Mannino, M., Di Pumpo, M., Fida, M., Starace, M., Apalla, Z., Romano, M. C., Riganti, J., Segura, S., Martinez, A. F., Fabbrocini, G., Sibaud, V., Peris, K., & on behalf of the EADV Task Force “Dermatology for Cancer Patients”. (2023). Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study. Cancers, 15(14), 3658. https://doi.org/10.3390/cancers15143658